Cargando…
Overexpression of wild-type or mutants forms of CEBPA alter normal human hematopoiesis
C/EBPα (CEBPA) is mutated in approximately 8 % of AML in both familial and sporadic AML and, with FLT3 and NPM1, has received most attention as a predictive marker of outcome in patients with normal karyotype disease. Mutations clustering to either the N- or C-terminal (N-and C-ter) portions of the...
Autores principales: | Quintana-Bustamante, Oscar, Smith, S.Lan-Lan, Griessinger, Emmanuel, Reyal, Yasmin, Vargaftig, Jacques, Lister, T. Andrew, Fitzgibbon, Jude, Bonnet, Dominique |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3378638/ https://www.ncbi.nlm.nih.gov/pubmed/22371011 http://dx.doi.org/10.1038/leu.2012.38 |
Ejemplares similares
-
Heterogeneous sensitivity of human Acute Myeloid Leukemia to ß-catenin down-modulation
por: Gandillet, Arnaud, et al.
Publicado: (2011) -
Acute myeloid leukemia xenograft success prediction: Saving time
por: Griessinger, Emmanuel, et al.
Publicado: (2018) -
Mutant CEBPA directly drives the expression of the targetable tumor-promoting factor CD73 in AML
por: Jakobsen, Janus S., et al.
Publicado: (2019) -
Frequency of Leukemic Initiating Cells does not depend on the xenotransplantation model used
por: Vargaftig, Jacques, et al.
Publicado: (2011) -
Induced cell-autonomous neutropenia systemically perturbs hematopoiesis in Cebpa enhancer-null mice
por: Avellino, Roberto, et al.
Publicado: (2022)